Prajwal Neupane
Prajwal Neupane is an expert in Oncology at Fukushima Medical University (Japan). Prajwal Neupane has authored 6 publications, the most recent in 2023. SLR score: 12 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2019 - 2023
Number : 6
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Immunological Responses Associated With Neoadjuvant Therapy in the Tumor Microenvironment of Esophageal Squamous Cell Carcinoma. PMID 37772585 — radiotherapy, cells, carcinoma, squamous cell, neoplasms, drug therapy, immune checkpoint inhibitors, neoadjuvant therapy, esophageal squamous cell carcinoma, therapeutics, tumor microenvironment, chemotherapy | Anticancer Res | 2023 | 0 |
| The mirage of domestic violence during COVID-19 pandemic in Nepal. PMID 35841620 — global health, pandemics, covid-19 | J Glob Health | 2022 | 4 |
| The Expression of Immune Checkpoint Receptors and Ligands in the Colorectal Cancer Tumor Microenvironment. PMID 34593437 — ligands, cells, colorectal neoplasms, t-lymphocytes, tumor microenvironment | Anticancer Res | 2021 | 11 |
| The effects of T-DXd on the expression of HLA class I and chemokines CXCL9/10/11 in HER2-overexpressing gastric cancer cells. PMID 34413454 — natural science disciplines, immunity, major histocompatibility complex, cells, stomach neoplasms, chemokines, t-lymphocytes, exhibitions as topic, up-regulation | Sci Rep | 2021 | 13 |
| The Nepalese health care system and challenges during COVID-19. PMID 33692885 — global health, covid-19 | J Glob Health | 2021 | 18 |
LeadR Networks
Main global connection map